Bengt Wretlind

Curriculum vitae (2013)

Born: January 5, 1940

Social status:Married, two sons (born 1973 and 1976).

Present position:Professor and Chief Physician, Division of Clinical Bacteriology, Huddinge

UniversityHospital

Education: Graduation from college 1958.

1967, MD, Karolinska Institutet

1974, Specialist in clinical bacteriology

1977, PhD, Karolinska Institutet

1978, Associate Professor, Karolinska Institutet

2000, Professor, Karolinska Institutet

Positions:1967 - 1969, Physician, Department of Infectious Diseases, Roslagstull Hosp, Stockholm, Sweden

1969 - 1978, Physician, Department of Clinical Microbiology, KarolinskaHospital, Stockholm

1978 Associate Professor, Karolinska Institutet

1979 Postdoctoral position: Research Associateship, Naval Medical Research Institute, Bethesda, Maryland, USA

1980, Physician, Department of Clinical Microbiology, KarolinskaHospital, Stockholm

1981-1984, Chief Physician and Acting Professor, Department of Clinical Microbiology, Karolinska Institutet at KarolinskaHospital, Stockholm

1985 - 1993, Chief Physician and Head of Department, Department of Clinical Bacteriology, DanderydHospital, Danderyd, Sweden

1994 - 1995, Acting Professor and Chief Physician, Division of Clinical Bacteriology, Karolinska Institutet at HuddingeUniversityHospital.

1996, Chief Physician and Head of Department, Department of Clinical Bacteriology, DanderydHospital, Danderyd.

1997, Chief Physician, Department of Clinical Microbiology, KarolinskaHospital

1998, Senior Lecturer and Chief Physician, Department Laboratory Medicine, Division of Clinical Bacteriology, Karolinska Institutet at HuddingeUniversityHospital.

Last position2000, April, Professor in Clinical Bacteriology and Chief Physician, Karolinska Institutet at Huddinge University Hospital

2006 April 1, Professor emeritus

TutoringPrincipal supervisor for 9 PhD students:

Laila Elsheikh, 1986

Annelie Brauner 1987

Gunnar Granström 1989

Shah Jalal 2000

John Danin 2003

Nagwa El Amin 2003

Emma Lindbäck 2006

Christian Giske 2007

Sohidul Islam 2008

Assistant supervisor for 11 PhD students

Publications:PhD thesis 1977: Role of proteases in the pathogenicity ofPseudomonas aeruginosa.

169 papers on various aspects of clinical bacteriology, especially pathogenicity, genetics and drug resistance mechanisms of Pseudomonas aeruginosa; and immune response in infectious diseases. About 100 abstracts from conferences and meetings.

original articles
  1. Wretlind, B; Möllby, R; Wadström, T. Separation of two hemolysins from Aeromonas hydrophila by isoelectric focusing. Infection and Immunity 4:503-505, 1971.
  1. Wretlind, B; Hedén, L; Wadström, T. Formation of extracellular haemolysin by Aeromonas hydrophila in relation to protease and staphylolytic enzyme. Journal of General Microbiology 78:57-65, 1973.
  1. Wretlind, B; Hedén, L; Sjöberg, L; Wadström, T. Production of enzymes and toxins by hospitalstrains of Pseudomonas aeruginosa in relation to serotype and phage-typing pattern. Journal of Medical Microbiology 6:91-100, 1973.
  1. Lagercrantz, R; Nyström, B; Wretlind, B. Staphylococci and infection in maternity wards. IV. Studies on a partial rooming-in system. Acta Paediatrica Scandinavica 62:621-624, 1973.
  1. Wretlind, B; Nord, C-E; Wadström, T. In vitro sensitivity of isolates of Pseudomonasaeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics. Scandinavian Journal of Infectious Diseases 6:49-52, 1974.
  1. Wadström, T; Söderlind, O; Möllby, R; Wretlind, B. Release of heat-labile enterotoxin from cells of E. coli strain 853/67. IRCS (Research on: Biochemistry; Biophysics; Microbiology) 2:1312, 1974.
  1. Wadström, T; Möllby, R; Jeansson, S; Wretlind, B. Biological studies on Ampholine carrier ampholytes. Science Tools 21:2-4, 1974.
  1. Nord, C-E; Wadström, T; Wretlind, B. Sensitivity of different Pseudomonas species and Aeromonas hydrophila to trimethoprim and sulfamethoxazole separately and in combination. Medical Microbiology and Immunology 160:1-7, 1974.
  1. Nord, C-E; Wadström, T; Wretlind, B. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrobial Agents and Chemotherapy 6:521-523, 1974.
  1. Wretlind, B; Goertz, G; Illéni, T; Lundell, S; Seger,B. Antibiotic sensitivity testing by zone-scanning of agar strips (a preliminary report). In: Automation in Microbiology and Immunology, pp. 293-304. Edited by C-G Hedén and T. Illéni. John Wiley & Sons, New York, 1975.
  1. Eneroth, CM; Lundberg, C; Wretlind, B. Antibiotic concentration in maxillary sinus secretion and in the sinus mucosa. Chemotherapy 21 (Suppl. 1):1-7, 1975.
  1. Nord, C-E; Sjöberg, L; Wadström, T; Wretlind, B. Characterization of three Aeromonas and nine Pseudomonas species by extracellular enzymes and haemolysins. Medical Microbiology and Immunology 161:79-87, 1975.
  1. Nord, C-E; Wadström, T; Wretlind, B. Antibiotic sensitivity of two Aeromonas and nine Pseudomonas species. Medical Microbiology and Immunology 161:89-97, 1975.
  1. Nord, C-E; Wadström, T; Dornbusch, K; Wretlind, B. Extracellular proteins in five clostridial species from human infections. Medical Microbiology and Immunology 161:145-154, 1975.
  1. Carenfelt, C; Eneroth, C-M; Lundberg, C; Wretlind, B. Evaluation of the antibiotic effect of treatment of maxillary sinusitis. Scandinavian Journal of Infectious Diseases 7:259-264, 1975.
  1. Palmblad, J; Wretlind, B. Fever and bacterial infections in acute leukemia. Opuscula Medica 21:20-22, 1976.
  1. Wadström, T; Ljungh, Å; Wretlind, B. Enterotoxin, haemolysin and cytolytic protein in Aeromonas hydrophila from human infections. Acta Pathologica et Microbiologica Scandinavica Section B 84:112-114, 1976.
  1. Wretlind, B; Gezelius, L. Sensitivity of isolates of Pseudomonas aeruginosa to amikacin (BB-K8), gentamicin, sisomicin and tobramycin. IRCS Medical Science: Microbiology; Pharmacology 4:156, 1976.
  1. Olsson, B; Nord, C-E; Wadström, T; Wretlind, B. Gel electrofocusing combined with zymogram techniques for the characterization of ß-lactamases from Gram negative bacteria. FEMS Microbiology Letters 1:157- 162, 1977.
  1. Nord, C-E; Wretlind, B; Dahlbäck, A. Evaluation of two test-kits - API and Oxi Ferm tube - for identification of oxidative-fermentative Gram-negative rods. Medical Microbiology and Immunology 163:93-97, 1977.
  1. Wretlind, B; Wadström, T. Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa. Journal of General Microbiology 103:319-327, 1977.
  1. Wretlind, B; Sjöberg, L; Wadström, T. Protease-deficient mutants of Pseudomonas aeruginosa: pleiotropic changes in activity of other extracellular enzymes. Journal of General Microbiology 103:329-336, 1977.
  1. Wretlind, B; Kronevi, T. Experimental infections with protease-deficient mutants of Pseudomonas aeruginosa in mice. Journal of Medical Microbiology 11:145-154, 1978.
  1. Ljungh, Å; Wretlind, B; Wadström, T. Evidence for enterotoxin and two cytolytic toxin in human isolates of Aeromonas hydrophila. In: Toxins: Animal, Plant and Microbial, pp. 947-960. Edited by P Rosenberg. Pergamon Press, Oxford and New York, 1978.
  1. Wretlind, B; Gezelius, L; Karlsson, I; Hagberg, R. In vitro activity of a new semisynthetic penicillin, PC-904, against ampicillin-resistant Gram-negative bacteria. In: Current Chemotherapy, pp. 638-641. American Society for Microbiology, Washington, DC, 1978.
  1. Carenfelt, C; Lundberg, C; Nord, C-E; Wretlind, B. Bacteriology of maxillary sinusitis in relation to quality of the retained secretion. Acta Oto-laryngologica 86:298-302, 1978.
  1. Pavlovskis, OR; Wretlind, B. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection. Infection and Immunity 24:181-187, 1979.
  1. Pavlovskis, OR; Wretlind, B; Hale, ML. The effect of Pseudomonas aeruginosa exotoxin A on antibody forming mouse spleen cells. In: Natural Toxins, pp. 425-429. Edited by D Eaker and T Wadström. Pergamon Press, Oxford and New York, 1980.
  1. Reimer, Å; Klementsson, K; Ursing, J; Wretlind, B. The mucociliary activity of the respiratory tract. 1. Inhibitory effects of products of Pseudomonas aeruginosa on rabbit trachea in vitro. Acta Oto-laryngologica 90:462-469, 1980.
  1. Pavlovskis, OR; Edman, DC; Leppla, SH; Wretlind, B; Lewis, LR; Martin, KE. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids. Infection and Immunity 32:681-689, 1981.
  1. Ljungh, Å; Wretlind, B; Möllby, R. Separation and characterization of enterotoxin and two haemolysins from Aeromonas hydrophila. Acta Pathologica et Microbiologica Scandinavica Section B 89:387-397, 1981.
  1. Pavlovskis, OR; Yaffe, LJ; Wretlind, B; Galloway, DR. Experimental Pseudomonas aeruginosa infections in burned mice and rats: description of a model. In: Experimental Bacterial and Parasitic Infections, pp. 103-108. Edited by G Keusch and T Wadström. Elsevier, New York, 1983.
  1. Howe, TR; Wretlind, B; Iglewski, BH. Comparison of two methods of genetic exchange in determination of the genetic locus of the structural gene for Pseudomonas aeruginosa elastase. Journal of Bacteriology 156:58-61, 1983.
  1. Wretlind, B; Pavlovskis, OR. Genetic mapping and characterization of Pseudomonas aeruginosa mutants defective in the formation of extracellular proteins. Journal of Bacteriology 158:801-808, 1984.
  1. Belfrage, P; Christensen, KK; Christensen, P; Faxelius, G; Feuerberg, Y; Lindén, V; Svenningsen, N; Wretlind, B. Transient increase of early-onset group B streptococcal septicemia. European Journal of Obstetrics, Gynecology and Reproductive Biology 17:377-382, 1984.
  1. Granström, M; Ericsson, A; Strandvik, B; Wretlind, B; Pavlovskis, OR; Berka, R; Vasil, ML. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatrica Scandinavica 73:772-777, 1984.
  1. Brauner, A; Høiby, N; Kjartansson, J; Kühn, I; Svenberg-Appelgren, P; Wretlind, B. Pseudomonas cepacia septicemia in patients with burns: report of two cases. Scandinavian Journal of Infectious Diseases 17:63-66, 1985.
  1. Granström, M; Wretlind, B; Markman, B; Pavlovskis, OR; Vasil, ML. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins. European Journal of Clinical Microbiology 4:197-200, 1985.
  1. Björklind, A; Wretlind, B; Möllegård, I; Schad, PA; Iglewski, BH; Cox, CD. Genetic mappingand characterization of Pseudomonas aeruginosa mutants that hyperproduce exoproteins. Journal of Bacteriology 162:1329-1331, 1985.
  1. Malmborg, A-S; Alfredsson, H; Strandvik, B; Wretlind, B. Sputum concentrations and clinical effects of imipenem treatment in patients with cystic fibrosis. Chemiotherapia 4 Supplement:910-911, 1985.
  1. Wretlind, B; Becker, K; Haas, D. Inc P-1 R plasmids decrease the serum resistance and the virulence of Pseudomonas aeruginosa. Journal of General Microbiology 131:2701-2704, 1985.
  1. Ringertz, S; Eriksson, B; Malmborg, A-S; Nyström, S; Wretlind, B. Use of the antimicrobial removal device prior to blood culture in patients on antibiotic therapy. European Journal of Clinical Microbiology 4:544-547, 1985.
  1. Brauner, A; Leissner, M; Wretlind, B; Julander, I; Svenson, SB; Källenius, G. Occurrence of P-fimbriated Escherichia coli in patients with bacteremia. European Journal of Clinical Microbiology 4:566-569, 1985.
  1. Elsheikh, LE; Abaas, S; Wretlind, B. Adherence of Pseudomonas aeruginosa to tracheal epithelial cells of mink. Studies on bacterial hydrophobicity and elastase production. Acta Pathologica, Microbiologica et Immunologica Scandinavica Section B 93:417-422, 1985.
  1. Herngren, L; Broberger, U; Wretlind, B. A simplified model for adjustment of gentamicin in newborn infants. Acta Paediatrica Scandinavica 75:198-204, 1986.
  1. Elsheikh, LE; Bergman, R; Cryz, Jr, SJ; Wretlind, B. A comparison of different methods for determining elastase activity of Pseudomonas aeruginosa strains from mink. Acta Pathologica, Microbiologica et Immunologica Scandinavica Section B 94:135-138, 1986.
  1. Brauner, A; Källenius, G; Wrangsell, G; Wretlind, B; Svenson, SB. Antibody responses to Escherichia coli J5 lipopolysaccharide and to Salmonella porin in patients with bacteraemia. Microbial Pathogenesis 1:475-481, 1986.
  1. Brauner, A; Källenius, G; Svenson, SB; Wrangsell, G; Wretlind, B. Antibody response to Escherichia coli J5 lipopolysaccharide in patients with bacteraemia. Microbial Pathogenesis 2:395-396, 1987.
  1. Filloux, A; Murgier, M; Wretlind, B; Lazdunski, A. Characterization of two Pseudomonas aeruginosa mutants with defective secretion of extracellular proteins and comparison with other mutants. FEMS Microbiology Letters 40:159-163, 1987.
  1. Elsheikh, LE; Kronevi, T; Wretlind, B; Abaas, S; Iglewski,BH. Assessment of elastase as a Pseudomonas aeruginosa virulence factor in experimental lung infection in mink. Veterinary Microbiology 13:281-289, 1987.
  1. Lindgren, V; Wretlind, B. Characterization of a Pseudomonas aeruginosa transposon insertion mutant with defective release of exoenzymes. Journal of General Microbiology 133:675-681, 1987.
  1. Wretlind, B; Björklind, A; Pavlovskis, OR. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection. Microbial Pathogenesis 2:397-404, 1987.
  1. Örtqvist, Å; Ransjö, U; Wretlind, B. Plasmid analysis as an epidemiological tool in neurosurgical infections with coagulase negative staphylococci. Epidemiology and Infection 98:231-239, 1987.
  1. Brauner, A; Boefgras, JM; Jacobson, SH; Kaijser, B; Källenius, G; Svenson, SB; Wretlind, B. The use of biochemical markers, serotype and fimbriation in the detection of Escherichia coli clones. Journal of General Microbiology, 133:2825-2834, 1987.
  1. Ericsson Hollsing, A; Granström, M; Vasil, ML; Wretlind, B; Strandvik, B. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Journal of Clinical Microbiology, 25:1868-1874, 1987.
  1. Brauner, A; Svenson, SB; Wretlind, B. Antibody response to lipid A and core oligosaccharide in patients with bacteraemia. Serodiagnosis and Immunotherapy, 1:431-440, 1987.
  1. Jacobson, SH; Tullus, K; Wretlind, B; Brauner, A. Aerobactin mediated iron uptake by Escherichia coli strains causing acute pyelonephritis and bacteraemia. Journal of Infection, 16:147-152, 1988.
  1. Strandvik, B; Malmborg, A-S; Bergan, T; Michalsen, H; Storrösten, OT; Wretlind, B. Imipenem/cilastatin, an alternative treatment of Pseudomonas infection in cystic fibrosis. Journal of Antimicrobial Chemotherapy, 21:471-480, 1988.
  1. Bally, M; Filloux, A; Murgier, M; Wretlind, B; Lazdunski, A. Cloning of xcp genes involved in protein secretion in Pseudomonas aeruginosa. In NATO ASI Series. Vol H16 Membrane Biogenesis, pp. 439-444. Edited by JAF Op den Kamp. Springer-Verlag, Berlin Heidelberg, 1988.
  1. Brauner, A; Svenson, SB; Wretlind, B. Immunological characterization of antibody responses to Escherichia coli Oantigens in bacteraemic patients. Serodiagnosis and Immunotherapy in Infectious Disease, 2:291-299, 1988.
  1. Karlsson, M; Möllegård, I; Stiernstedt, G; Henriksson, A; Wretlind, B. Characterization of antibody response in patients with Borrelia meningitis. Serodiagnosis and Immunotherapy in Infectious Disease, 2:375-386, 1988.
  1. Granström, G; Wretlind, B; Salenstedt, C-R; Granström, M. Evaluation of serological assays for diagnosis of whooping cough. Journal of Clinical Microbiology, 26:1018-1023, 1988.
  1. Granström, M; Wretlind, B; Markman, B; Cryz, S. Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans. Journal of Clinical Microbiology, 26:2257-2261, 1988.
  1. Filloux, A; Bally, M; Murgier, M; Wretlind, B; Lazdunski, A. Cloning of xcp genes located at the 55 min region of the chromosome and involved in protein secretion in Pseudomonas aeruginosa. Molecular Microbiology, 3:261-265, 1989.
  1. Brauner, A; Kaijser, B; Svenson, SB; Wretlind, B. Determination of antibody response in patients with bacteraemia to eight Escherichia coli O antigens. Serodiagnosis and Immunotherapy in Infectious Disease, 3:65-73, 1989.
  1. Ostroff, RM; Wretlind, B; Vasil, ML. Mutations in the hemolytic phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate limiting conditions. Infection and Immunity, 57:1369-1373, 1989.
  1. Brauner, A; Jacobson, SH; Kaijser, B; Svenson, SB; Wretlind, B. Serological responses to eight Escherichia coli O antigens in female patients with acute pyelonephritis. Serodiagnosis and Immunotherapy in Infectious Disease, 3:141- 148, 1989.
  1. Brauner, A; Jacobson, SH; Svenson, SB; Wretlind, B. Inhibition of antibody binding to homologous Escherichia coli lipopolysaccharides with purified Oantigen polysaccharides in sera from patients with acute pyelonephritis. Serodiagnosis and Immunotherapy in Infectious Disease, 3:211-217, 1989
  1. Bally, M; Wretlind, B; Lazdunski, A. Protein secretion in Pseudomonas aeruginosa: Molecular cloning and characterization of the xcp-1 gene. Journal of Bacteriology, 171:4342-4348, 1989.
  1. Hemlin, C; Brauner, A; Carenfelt, C; Wretlind, B. Nasopharyngeal culture with quantitative analysis of pathogens in chronic otitis media with effusion. Effects on pathogen yield of different swabs and transport methods. APMIS, 97:606-610, 1989
  1. Hemlin, C; Brauner, A; Carenfelt, C; Wretlind, B. Test-retest reliability of the nasopharyngeal culture in children. APMIS, 97:887-890, 1989.
  1. Karlsson, M; Möllegård, I; Stiernstedt, G; Wretlind, B. Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis. European Journal of Clinical Microbiology and Infectious Diseases, 8:871-878, 1989.
  1. Lindgren, V; Ostroff, R; Vasil, ML; Wretlind, B. Genetic mapping of the structural gene for phospholipase C in Pseudomonas aeruginosa PAO. Journal of Bacteriology, 172:1155-1156, 1990.
  1. Karlsson, M; Stiernstedt, G; Granström, M; Åsbrink, E; Wretlind, B. Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis. European Journal of Clinical Microbiology and Infectious Diseases, 9:169-177, 1990.
  1. Granström, G; Granström, M; Anderson, M; Lindquist, U; Leontein, K; Svenson, SB; Wretlind, B.Bordetella pertussis lipopolysaccharide as antigen in ELISA for serological diagnosis of whooping cough. Serodiagnosis and Immunotherapy in Infectious Disease, 4:151-158, 1990.
  1. Enocksson, E; Wretlind, B; Sterner, G; Anzén, B. Listeriosis during pregnancy and in neonates. Scandinavian Journal of Infectious Diseases, Suppl. 71:89-94, 1990.
  1. Brauner, A; Hylander, B; Wretlind, B; Östenson, C-G; Kühn, I.Escherichia coli populations from diabetic and non-diabetic patients with bacteraemia and faecal samples from healthy subjects - a comparative study. Epidemiology and Infection, 105:533-540, 1990.
  1. Brauner, A; Cryz Jr, SJ; Granström, M; Wretlind, B. Serological responses to eight Klebsiella pneumoniae capsular polysaccharide antigens in patients with bacteremia. Serodiagnosis and Immunotherapy in Infectious Disease, 4:487-493, 1990.
  1. Swedish Study Group. A randomized multicenter trial of pefloxacin plus metronidazol versus gentamicin plus metronidazol in the treatment of severe intraabdominal infections. Journal of Antimicrobial Chemotherapy 26 Suppl. B:173-180, 1990.
  1. Granström, G; Wretlind, B; Granström, M. Diagnostic value of clinical and bacteriological findings in pertussis. Journal of Infection, 22:17-26, 1991.
  1. Hemlin, C; Brauner, A; Carenfelt, C; Wretlind, B. Nasopharyngeal flora in otitis media with effusion. A comparative semiquantitative analysis. Acta Otolaryngologica (Stockholm), 111:556-561, 1991.
  1. Brauner, A; Kaijser, B; Wretlind, B; Kühn, I. Characterization of Escherichia coli isolated in blood, urine and faeces from bacteraemic patients and possible spread of infection. APMIS 99:381-386, 1991.
  1. Szanto, E; Granfors, K; Wretlind, B. Acute anterior uveitis, arthritides and enteric antigens. Clinical Rheumatology, 10:395-400, 1991.
  1. Eriksson, M; Granström, G; Wretlind, B; Granström, M; Askelöf, P. Bordetella pertussis adenylate cyclase activity in nasopharyngeal aspirates for rapid diagnosis of whooping cough in relation to culture and serology. Scandinavian Journal of Infectious Diseases, 23:731-735, 1992.
  1. Wiström, J; Jertborn, M; Ekwall, E; Norlin, K; Söderquist, B; Strömberg, A; Lundholm, R; Hogevik, H; Lagergren, L; Englund, G; Norrby, SR; The Swedish Study Group. Empiric treatment of acute diarrheal disease with norfloxacin: a placebo-controlled study. Annals of Internal Medicine, 117:202-208, 1992.
  1. Wretlind, B; Strömberg, A; Östlund, L; Sjögren, E; Kaijser, B. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. Scandinavian Journal of Infectious Diseases, 24:685-686, 1992.
  1. Brismar, B; Malmborg, AS; Tunevall, G; Wretlind, B; Bergman, L; Mentzing, LO; Nyström, PO; Kihlström, E; Bäckstrand, B; Skau, T; Kasholm-Tegve, B; Sjöberg, L; Olsson-Liljequist, B; Tally, FP; Gatenbeck, L; Eklund, AE; Nord, CE.. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intraabdomonal infections. Antimicrobial Agents and Chemotherapy, 36:2766-2773, 1992.
  1. Bygdeman, SM; Rudén, A-K; Jonsson, A; Lidbrink, P; Olofsson, M-B; Bäckman, M; Gästrin, B; Kallings, I; Ramberg, M; Rylander, M; Wretlind, B. Antibiotic susceptibility, serovars and auxotypes of gonococcal isolates in Stockholm, Sweden. Relation to geographical origin of the infection. International Journal of STD & AIDS, 4:33-40, 1993.
  1. Eklund, AE; Nord, CE; The Swedish Study Group. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Journal of Antimicrobial Chemotherapy, 31 Suppl. A: 79-85, 1993.
  1. Brauner, A; Cryz, SJ; Granström, M; Hanson, HS; Löfstrand, L; Strandvik, B; Wretlind, B. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia. European Journal of Clinical Microbiology and Infectious Diseases 12:430-436, 1993.
  1. Brauner, A; Hylander, B; Wretlind, B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. American Journal of Kidney Diseases, 22:430-435, 1993.
  1. Gårdlund, B; Sjölin, J; Nilsson, A; Roll, M; Wickerts, C-J; Wikström, B; Wretlind, B. Plasmapheresis for the treatment of primary septic shock in humans. Scandinavian Journal of Infectious Diseases, 25:757-761, 1993.
  1. Lutsar, I; Narska, M; Gontmacher, A; Wretlind, B. Cerebrospinal fluid IL-6 levels in children with and without infections in the central nervous system. Pediatric Research 36, A59, 1994.
  1. Tullus, K; Fituri, O; Burman, LG; Wretlind, B; Brauner, A. Interleukin-6 and interleukin-8 in the urine of children with pyelonephritis. Pediatric Nephrology, 8:280-284, 1994.
  1. Jacobson, SH; Hylander, B; Wretlind, B; Brauner, A. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron, 67, 172-179, 1994.
  1. Tullus, K; Fituri, O; Linné, T; Escobar-Billing, R; Wikstad, I; Karlsson, A; Burman, LG; Wretlind, B; Brauner, A. Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up. Pediatric Radiology, 24, 513-515, 1994.
  1. The Swedish CDAD Study Group. Treatment of Clostridium difficile associated diarrhea and colitis with an oral preparation of teicoplanin; a dose finding study. Scandinavian Journal of Infectious Diseases, 26:309-316, 1994.
  1. Eriksson, S; Granström, L; Olander, B; Wretlind, B. Sensitivity of interleukin-6 and C-reactive protein concentrations in the diagnosis of acute appendicitis. European Journal of Surgery, 161, 41-45, 1995.
  1. Günther, G; Gårdlund, B; Hast, R; Kimby, E; Nordin, M; Wretlind, B. Endotoxaemia and inflammatory mediators in febrile patients with haematological disease. Journal of Internal Medicine, 237, 27-33, 1995
  1. Raqib, R; Lindberg, AA; Wretlind, B; Bardhan, PK; Andersson, U; Andersson, J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infection and Immunity, 63, 289-296, 1995.
  1. Raqib, R; Wretlind, B; Andersson, J; Lindberg, AA.Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. Journal of Infectious Diseases, 171, 376-384, 1995.
  1. Islam, D; Wretlind, B; Ryd, M; Lindberg, AA; Christensson, B. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis. Infection and Immunity, 63, 2054-2061, 1995.
  1. Gårdlund, B; Sjölin, J; Nilsson, A; Roll, M; Wickerts, C-J; Wretlind, B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. Journal of Infectious Diseases, 172, 296-301, 1995.
  1. Raqib, R; Lindberg, AA; Björk, L; Bardhan, PK; Wretlind, B; Andersson, U; Andersson, J. Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor  type I receptors at the local site during the acute phase of Shigella infection. Infection and Immunity, 63, 3079-3087, 1995.
  1. Örtqvist, Å; Hedlund, J; Wretlind, B; Carlström, A; Kalin, M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community acquired pneumonia. Scandinavian Journal of Infectious Diseases, 27, 457-462, 1995.
  1. Minh, NB; Tram, LN; Trach, DD; Wretlind, B; Kärnell, A.